DESAIN VAKSIN HUMAN PAPILLOMAVIRUS TIPE 16 BERDASARKAN HUMAN LEUKOCYTE ANTIGEN POPULASI INDONESIA MELALUI PENDEKATAN REVERSE VACCINOLOGY
Cervical cancer is the second most common cancer case after breast cancer in Indonesia. About 50-60% of cancer cases are triggered by High Risk Human Papillomavirus (HR-HPV), HPV-16. Although vaccine can protect 70%-90% against the HR-HPV strain, the vaccine is not therapeutic virally infected pe...
Saved in:
| Main Author: | |
|---|---|
| Format: | Final Project |
| Language: | Indonesia |
| Online Access: | https://digilib.itb.ac.id/gdl/view/57963 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Institut Teknologi Bandung |
| Language: | Indonesia |